TRAVERE THERAPEUTICS, INC. Deferred Tax Assets, Other
TRAVERE THERAPEUTICS, INC. (TVTX) had Deferred Tax Assets, Other of $0 as of 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredTaxAssetsOther · last filed 2020-02-24
- 2019-12-31: Deferred Tax Assets, Other $0.00.
- 2018-12-31: Deferred Tax Assets, Other $555.00K.
- 2017-12-31: Deferred Tax Assets, Other $358.00K.
- 2016-12-31: Deferred Tax Assets, Other $30.00K.
| Period end | Deferred Tax Assets, Other | Deferred Tax Assets, Other as first filed |
|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-24 | |
| 2018-12-31 | $555.00K 10-K · filed 2020-02-24 | |
| 2017-12-31 | $358.00K 10-K · filed 2019-02-26 | |
| 2016-12-31 | $30.00K 10-K · filed 2018-07-06 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-01 | |
| 2014-12-31 | $1.43M 10-K · filed 2016-02-26 | $1.43K 10-K · filed 2015-03-11 |
| 2013-12-31 | $610.00 10-K · filed 2015-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |